Patient- or physician-oriented marketing: What drives primary demand for prescription drugs?

Journal of Marketing Research

Volumn 47, Issue 1, 2010, Pages 103-121

  Marc, Fischer ^a   Sönke, Albers ^b  

^a UNIVERSITY OF PASSAU   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Econometric models; Marketing mix effects; Pharmaceutical marketing; Primary demand effects

Indexed keywords

EID: 76749150986     PISSN: 00222437     EISSN: None     Source Type: Journal    
DOI: 10.1509/jmkr.47.1.103     Document Type: Article

References (42)

1. Arellano, Manual (2003), Panel Data Econometrics. Oxford: Oxford University Press.
2. Arora, Neeraj, Greg M. Allenby, and James L. Ginter (1998), "A Hierarchical Bayes Model of Primary and Secondary Demand," Marketing Science, 17 (1), 29-44. (Pubitemid 128069458)
3. Belsley, David A. (1991), Conditioning Diagnostics: Collinearity and Weak Data in Regression. New York: John Wiley & Sons.
4. Berndt, Ernst R., Linda Bui, David R. Reily, and Glen L. Urban (1995), "Information, Marketing, and Pricing in the U.S. Antiulcer Drug Market," American Economic Review: Papers and Proceedings, 85 (2), 100-105.
5. - and N. Eugene Savin (1975), "Estimation and Hypothesis Testing in Singular Equation Systems with Autoregressive Disturbances," Econometrica, 43 (5-6), 937-957
6. Bodapati, Anand and Sachin Gupta (2004), "The Recoverability of Segmentation Structure from Store-Level Aggregate Data," Journal of Marketing Research, 41 (August), 351-364
7. Bowman, Douglas and Hubert Gatignon (1996), "Order of Entry as a Moderator of the Effect of the Marketing Mix on Market Share," Marketing Science, 15 (3), 222-242 (Pubitemid 126143195)
8. Brockhoff, Klaus (1967), "A Test for the Product Life Cycle," Econométrica, 35 (3-4), 472-484
9. Calfee, John E., Clifford Winston, and Randolph Stempski (2002), "Direct-to-Consumer Advertising and the Demand for Cholesterol-Reducing Drugs," Journal of Law and Economics, 45 (October), 673-690 (Pubitemid 36853925)
10. Carpenter, Gregory S. and Kent Nakamoto (1989), "Consumer Preference Formation and Pioneering Advantage," Journal of Marketing Research, 26 (August), 285-298
11. Chintagunta, Pradeep K. and Ramarao Desiraju (2005), "Strategic Pricing and Detailing Behavior in International Markets," Marketing Science, 24 (1), 67-80.
12. -, Jean-Pierre Dubé, and Khim Yong Goh (2005), "Beyond the Endogeneity Bias: The Effect of Unmeasured Brand Characteristics on Household-Level Brand Choice Models," Management Science, 51 (5), 832-849
13. Ellison, Sara Fisher, Iain Cockburn, Zvi Griliches, and Jerry Hausman (1997), "Characteristics of Demand for a Pharmaceutical Product: An Examination of Four Cephalosporins," RAND Journal of Economics, 28 (3), 426-446
14. EphMRA (2006), "EphMRA Anatomical Classification Guidelines 2006," European Pharmaceutical Marketing Research Association, (accessed January 30, 2006), [available at http://www.ephmra.org].
15. Fischer, Marc, Venkatesh Shankar, and Michel Clement (2005), "Can a Late Mover Use International Market Entry Strategy to Challenge the Pioneer?" MSI Report No. 05-118. Cambridge, MA: Marketing Science Institute.
16. Greene, William H. (2004), Econometric Analysis, 5th ed. Upper Saddle River, NJ: Prentice Hall.
17. Guadagni, Peter M. and John D.C. Little (1983), "A Logit Model of Brand Choice Calibrated on Scanner Data," Marketing Science, 2 (3), 203-238.
18. Gupta, Sunil (1988), "Impact of Sales Promotion on When, What, and How Much to Buy," Journal of Marketing Research, 25 (November), 342-355
19. Hanssens, Dominique M., Leonard J. Parsons, and Randall L. Schultz (2001), Market Response Models, Econometric and Time Series Analysis, 2d ed. Boston: Kluwer Academic Publishers.
20. Hollon, Matthew F. (1999), "Direct-to-Consumer Marketing of Prescription Drugs, Creating Consumer Demand," Journal of the American Medical Association, 281 (4), 382-384
21. Iizuka, Toshiaki and Ginger Z. Jin (2005), "The Effect of Prescription Drug Advertising on Doctor Visits," Journal of Economics and Management Strategy, 14 (3), 701-727.
22. Johnston, J. (1984), Econometric Methods, 3d ed. New York: McGraw-Hill.
23. Kalyanaram, Gurumurthy, William T. Robinson, and Glen L. Urban (1995), "Order of Market Entry: Established Empirical Generalizations, Emerging Empirical Generalizations, and Future Research," Marketing Science, 14 (3/2), G212-21.
24. Lieberman, Marvin B. and David B. Montgomery (1988), "FirstMover Advantages," Strategic Management Journal, 9 (Special Issue), 41-58.
25. Manchanda, Puneet and Elisabeth Honka (2005), "The Effects and Role of Direct-to-Physician Marketing in the Pharmaceutical Industry: An Integrative Review," Yale Journal of Health Policy, Law and Ethics, 5 (2), 785-822.
26. Nair, Harikesh, Jean-Pierre Dubé, and Pradeep Chintagunta (2005), "Accounting for Primary and Secondary Demand Effects with Aggregate Data," Marketing Science, 24 (3), 444-460
27. Narayanan, Sridhar, Ramarao Desiraju, and Pradeep K. Chintagunta (2004), "Return on Investment Implications for Pharmaceutical Promotional Expenditures: The Role of Marketing-Mix Interactions," Journal of Marketing, 68 (October), 90-105.
28. Nijs, Vincent R., Marnik G. Dekimpe, Jan-Benedict E.M. Steenkamp, and Dominique M. Hanssens (2001), 'The Category-Demand Effects of Price Promotions," Marketing Science, 20 (1), 1-22.
29. Rosenthal, Meredith B., Ernst R. Berndt, Julie M. Donohue, Richard G. Frank, and Arnold M. Epstein (2003), "Demand Effects of Recent Changes in Prescription Drug Promotion," working paper, Department of Health Policy and Management, Harvard School of Public Health.
30. Sethuraman, Raj and Gerard J. Tellis (1991), "An Analysis of the Trade-Off Between Advertising and Price Discounting," Journal of Marketing Research, 28 (May), 160-174
31. Sorescu, Alina B., Rajesh K. Chandy, and Jaideep C. Prabhu (2003), "Sources and Financial Consequences of Radical Innovation: Insights from Pharmaceuticals," Journal of Marketing, 67 (October), 82-102.
32. Srinivasan, Shuba, Koen Pauwels, Dominique M. Hanssens, and Marnik G. Dekimpe (2004), "Do Promotions Benefit Manufacturers, Retailers, or Both?" Management Science, 50 (5), 617-629
33. Tellis, Gerard J. and Philip Hans Franses (2006), "Optimal Data Interval for Estimating Advertising Response," Marketing Science, 25 (3), 217-229
34. Urban, G.L., T. Carter, S. Gaskin, and Z. Mucha (1986), "Market Share Rewards to Pioneering Brands: An Empirical Analysis and Strategic Implications," Management Science, 32 (6), 645-659
35. Van Heerde, Harald J., Sachin Gupta, and Dick R. Wittink (2003), "Is 75% of the Sales Promotion Bump Due to Brand Switching? No, Only 33% Is," Journal of Marketing Research, 40 (November), 481-491
36. -, Peter S.H. Leeflang, and Dick R. Wittink (2004), "Decomposing the Sales Promotion Bump with Store Data," Marketing Science, 23 (3), 317-334
37. -, Carl F. Mela, and Puneet Manchanda (2004), "The Dynamic Effect of Innovation on Market Structure," Journal of Marketing Research, 41 (May), 166-183 (Pubitemid 38671100)
38. Vermunt, Jeroen K. and Kay Magidson (2005), Technical Guide for Latent GOLD 4.0: Basic and Advanced. Belmont, MA: Statistical Innovations Inc.
39. Wilkes, Michael S., Robert A. Bell, and Richard L. Kravitz (2000), "Direct-to-Consumer Prescription Drug Advertising: Trends, Impact, and Implications," Health Affairs, 9 (2), 110-128
40. Wittink, Dick R. (2002), "Analysis of ROI for Pharmaceutical Promotions (ARPP)," presentation to the Association of Medical Publications, (October 26, 2005), [available at http://www.vioworks.com/clients/ amp].
41. Wolfe, Sidney M. (2002), "Direct-to-Consumer Advertising-Education or Promotion?" The New England Journal of Medicine, 346 (7), 524-526
42. Wosinska, Marta (2002), "Just What the Patient Ordered? Directto-Consumer Advertising and the Demand for Pharmaceutical Products," Working Paper No. 03-058, Harvard Business School, Harvard University.